LEAP THERAPEUTICS INC (LPTX)
US52187K2006 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to LPTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.99. This target is 275.71% above the current price.
LPTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about LPTX.
In the previous month the buy percentage consensus was at a similar level.
LPTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-19 | Baird | Maintains | Outperform -> Outperform |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-20 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-14 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-06-23 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-13 | Mizuho | Reiterate | Buy |
| 2023-03-27 | Raymond James | Maintains | Outperform |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-17 | Mizuho | Maintains | Buy |
| 2023-01-27 | Mizuho | Maintains | Buy |
| 2023-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-11 | Raymond James | Maintains | Outperform |
| 2022-08-15 | Raymond James | Maintains | Outperform |
| 2022-07-13 | Raymond James | Maintains | Outperform |
| 2021-10-04 | Mizuho | Initiate | Buy |
| 2021-09-14 | Raymond James | Maintains | Outperform |
| 2021-03-02 | Raymond James | Maintains | Outperform |